These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

182 related items for PubMed ID: 5004576

  • 1. [Test of short-term monotherapy in the clinical evaluation of the action of antitubercular agents].
    Anastasatu C, Bercea O, Marcian S, Ceicu A.
    Arch Monaldi; 1971; 26(4):291-9. PubMed ID: 5004576
    [No Abstract] [Full Text] [Related]

  • 2. [Ethambutol in the treatment of chronic pulmonary tuberculosis in patients excreting organisms resistant to several antitubercular agents].
    Bek-Lissner E, Rózewska M.
    Gruzlica; 1971 Jul; 39(7):643-7. PubMed ID: 5000656
    [No Abstract] [Full Text] [Related]

  • 3. [Double antibacterial therapy in untreated tuberculosis. Retrospective study of 120 unselected patients treated between 1972 and 1974].
    Augé C, Lecocguic Y, Touaty E, Bussi S, Pariente R.
    Rev Fr Mal Respir; 1982 Jul; 10(6):391-9. PubMed ID: 6819611
    [No Abstract] [Full Text] [Related]

  • 4. [Short-term chemotherapy of pulmonary tuberculosis. Pilot study].
    Poppe de Figueiredo F, Brito AA, Laborne Valle JH, Tavares PM, Trannin PL.
    Bull Int Union Tuberc; 1974 Jul; 49(1):411-7. PubMed ID: 4619561
    [No Abstract] [Full Text] [Related]

  • 5. Short-course treatment regimens for patients with tuberculosis.
    Dutt AK, Stead WW.
    Arch Intern Med; 1980 Jun; 140(6):827-9. PubMed ID: 6770770
    [No Abstract] [Full Text] [Related]

  • 6. Modern methods for assessing the drugs used in the chemotherapy of mycobacterial disease.
    Mitchison DA.
    Soc Appl Bacteriol Symp Ser; 1996 Jun; 25():72S-80S. PubMed ID: 8972122
    [No Abstract] [Full Text] [Related]

  • 7. Rifampicin and ethambutol in the treatment of drug resistant and far advanced pulmonary tuberculosis (with a note on capreomycin).
    Pines A, Raafat H, Siddiqui GM.
    J Ir Med Assoc; 1970 Mar; 63(393):82-5. PubMed ID: 4984340
    [No Abstract] [Full Text] [Related]

  • 8. [Comparative data from an experimental-clinical study of new antituberculosis drugs].
    Utkin VV.
    Antibiotiki; 1972 Sep; 17(9):851-6. PubMed ID: 4631726
    [No Abstract] [Full Text] [Related]

  • 9. [Mode of action of "tuverculostatics". Consequences for the therapy].
    Krebs A.
    Z Tuberk Erkr Thoraxorg; 1968 Sep; 128(1):208-17. PubMed ID: 4973006
    [No Abstract] [Full Text] [Related]

  • 10. Early bactericidal activity of high-dose rifampin in patients with pulmonary tuberculosis evidenced by positive sputum smears.
    Diacon AH, Patientia RF, Venter A, van Helden PD, Smith PJ, McIlleron H, Maritz JS, Donald PR.
    Antimicrob Agents Chemother; 2007 Aug; 51(8):2994-6. PubMed ID: 17517849
    [Abstract] [Full Text] [Related]

  • 11. [Early results of sputum-positive patients with newly-detected pulmonary tuberculosis with rifampicin combined with isoniazid and SM (preliminary report)].
    Ropek M, Szymański A, Banaszkiewicz H, Chetkowski A, Czaplińska-Jóźwiak E, Dabrowska-Solecka Z, Ignaczak J, Kondratowicz W, Królikowska H, Pawlik J, Pawlowska I, Sliwińska M, Szuster I, Szymánska W.
    Gruzlica; 1973 Jul; 41(7):777-80. PubMed ID: 4730978
    [No Abstract] [Full Text] [Related]

  • 12. [Effectiveness of ethambutol in chronic pulmonary tuberculosis].
    Golli V, Stefanin E, Chiper P, Stefănescu I, Popescu-Crivina IM, Anghel E, Kosinski E, Daha A, Kosinski M, Floricel N.
    Ftiziologia; 1972 Jul; 21(5):489-94. PubMed ID: 4632131
    [No Abstract] [Full Text] [Related]

  • 13. Modern short-course regimens in the treatment of tuberculosis.
    Fox W.
    Rev Ig Bacteriol Virusol Parazitol Epidemiol Pneumoftiziol Pneumoftiziol; 1985 Jul; 34(2):122-32. PubMed ID: 2999948
    [No Abstract] [Full Text] [Related]

  • 14. [Treatment of pleural and pulmonary tuberculosis by drug combinations including rifampicin. Early results].
    Cornudella R, Garcia-Besada JA, Castellano A.
    Rev Clin Esp; 1972 Jul 15; 126(1):59-64. PubMed ID: 5080189
    [No Abstract] [Full Text] [Related]

  • 15. The pathogenicity of Mycobacterium tuberculosis during chemotherapy.
    Clancy LJ, Kelly P, O'Reilly L, Byrne C, Costello E.
    Eur Respir J; 1990 Apr 15; 3(4):399-402. PubMed ID: 2114307
    [Abstract] [Full Text] [Related]

  • 16. [Maximum therapeutic efficiency of a guternary antitubercular preparation. (Streptomycin-ethambutol-rifampicin-isoniazid)].
    Almansa de Cara S.
    Rev Clin Esp; 1972 May 31; 125(4):353-6. PubMed ID: 5080180
    [No Abstract] [Full Text] [Related]

  • 17. Factors influencing time to smear conversion in patients with smear-positive pulmonary tuberculosis.
    Wang JY, Lee LN, Yu CJ, Chien YJ, Yang PC, Tami Group.
    Respirology; 2009 Sep 31; 14(7):1012-9. PubMed ID: 19659516
    [Abstract] [Full Text] [Related]

  • 18. [Intermittent chemotherapy of chronic forms of pulmonary tuberculosis].
    Ershov AI, Tikhonov VA, Zheltukhina NI, Chesmochakova IV.
    Probl Tuberk; 1976 Feb 31; (21):31-4. PubMed ID: 817283
    [No Abstract] [Full Text] [Related]

  • 19. Combined treatment with rifampicin-ethambutol-capreomycin in chronic open pulmonary tuberculosis.
    Virchow C, Flemming J.
    Acta Tuberc Pneumol Belg; 1969 Feb 31; 60(3):466-70. PubMed ID: 5371671
    [No Abstract] [Full Text] [Related]

  • 20. Quantitative bacteriology in the clinical testing of new antituberculosis drugs.
    Wallace AT.
    Tubercle; 1969 Mar 31; 50():Suppl:47-9. PubMed ID: 4990183
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 10.